TY - JOUR
T1 - Cost Effectiveness of Salpingectomy Compared With Vasectomy for Permanent Contraception
AU - Pearson, Amy
AU - Shvartsman, Katerina
AU - Zeng, Wu
AU - Brown, Jill
N1 - Publisher Copyright:
© 2025
PY - 2025/12
Y1 - 2025/12
N2 - OBJECTIVE: – To evaluate the cost effectiveness of salpingectomy compared with vasectomy for couples seeking permanent contraception.METHODS: – We developed a decision tree model that used TreeAge to evaluate the cost effectiveness of vasectomy compared with salpingectomy for a hypothetical cohort of 800, 000 people, the number of male and female patients who undergo permanent contraception procedures in the United States annually. Effectiveness was expressed in quality-adjusted life-years (QALYs), and the willingness-to-pay (WTP) threshold was set to $100, 000 per QALY gained or lost. We derived costs, probabilities, and utilities from the literature, and estimated the incremental cost-effectiveness ratio (ICER) between the two strategies. We completed a probabilistic sensitivity analysis with 10, 000 simulations and created a cost-effectiveness acceptability curve for WTP thresholds from $0 to $200, 000. Secondary outcomes included the number of unintended pregnancies, ovarian cancer cases, and ovarian cancer deaths.RESULTS: – Salpingectomy was not a cost-effective strategy, with an ICER of $143, 769 per QALY gained compared with vasectomy. Probabilistic sensitivity analysis showed that the chance of vasectomy being cost effective was 81.5% but decreased to 14.7% with a WTP threshold of $200, 000. Annually, salpingectomy was associated with 1, 215 fewer unintended pregnancies, 6, 085 fewer ovarian cancer cases, and 4, 921 fewer ovarian cancer deaths compared with vasectomy.CONCLUSION: – Salpingectomy is not cost effective compared with vasectomy at a WTP threshold of $100, 000, despite lower unintended pregnancy rates and societal ovarian cancer burden. Shared decision making, including a discussion of the long-term health benefits of salpingectomy, is important for couples deciding on permanent contraception procedures.
AB - OBJECTIVE: – To evaluate the cost effectiveness of salpingectomy compared with vasectomy for couples seeking permanent contraception.METHODS: – We developed a decision tree model that used TreeAge to evaluate the cost effectiveness of vasectomy compared with salpingectomy for a hypothetical cohort of 800, 000 people, the number of male and female patients who undergo permanent contraception procedures in the United States annually. Effectiveness was expressed in quality-adjusted life-years (QALYs), and the willingness-to-pay (WTP) threshold was set to $100, 000 per QALY gained or lost. We derived costs, probabilities, and utilities from the literature, and estimated the incremental cost-effectiveness ratio (ICER) between the two strategies. We completed a probabilistic sensitivity analysis with 10, 000 simulations and created a cost-effectiveness acceptability curve for WTP thresholds from $0 to $200, 000. Secondary outcomes included the number of unintended pregnancies, ovarian cancer cases, and ovarian cancer deaths.RESULTS: – Salpingectomy was not a cost-effective strategy, with an ICER of $143, 769 per QALY gained compared with vasectomy. Probabilistic sensitivity analysis showed that the chance of vasectomy being cost effective was 81.5% but decreased to 14.7% with a WTP threshold of $200, 000. Annually, salpingectomy was associated with 1, 215 fewer unintended pregnancies, 6, 085 fewer ovarian cancer cases, and 4, 921 fewer ovarian cancer deaths compared with vasectomy.CONCLUSION: – Salpingectomy is not cost effective compared with vasectomy at a WTP threshold of $100, 000, despite lower unintended pregnancy rates and societal ovarian cancer burden. Shared decision making, including a discussion of the long-term health benefits of salpingectomy, is important for couples deciding on permanent contraception procedures.
UR - http://www.scopus.com/inward/record.url?scp=105014635632&partnerID=8YFLogxK
U2 - 10.1097/AOG.0000000000006042
DO - 10.1097/AOG.0000000000006042
M3 - Article
C2 - 40875993
AN - SCOPUS:105014635632
SN - 0029-7844
VL - 146
SP - 911
EP - 917
JO - Obstetrics and gynecology
JF - Obstetrics and gynecology
IS - 6
ER -